Comparison of long-term outcome after endovascular therapy versus bypass surgery in claudication patients with trans-atlantic inter-society consensus-II C and d femoropopliteal disease

Circulation Journal

Volumn 78, Issue 2, 2014, Pages 457-464

  Aihara, Hideaki ^a   Soga, Yoshimitsu ^b   Mii, Shinsuke ^c   Okazaki, Jin ^b   Yamaoka, Terutoshi ^d   Kamoi, Daisuke ^e   Shintani, Yoshiaki ^f   Ishikawa, Toshinobu ^g  

^a TSUKUBA MEDICAL CENTER HOSPITAL   (Japan)

^b KOKURA MEMORIAL HOSPITAL   (Japan)

^c STEEL MEMORIAL YAWATA HOSPITAL   (Japan)

^d MATSUYAMA RED CROSS HOSPITAL   (Japan)

^e Nagoya Kyoritsu Hospital   (Japan)

^f Shin Koga Hospital   (Japan)

^g Miyazaki Medical Association Hospital   (Japan)

Author keywords

Bypass surgery; Endovascular therapy; Intermittent claudication; Long term outcome

Indexed keywords

AGED; ARTICLE; BYPASS SURGERY; ENDOVASCULAR SURGERY; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE COMPLICATION; RECANALIZATION; RETROSPECTIVE STUDY; TRANS ATLANTIC INTER SOCIETY CONSENSUS II C FEMOROPOPLITEAL DISEASE; TRANS ATLANTIC INTER SOCIETY CONSENSUS II D FEMOROPOPLITEAL DISEASE; TREATMENT OUTCOME; VASCULAR PATENCY; VERY ELDERLY; AXILLOFEMORAL ARTERY ANASTOMOSIS; CLINICAL TRIAL; COMPARATIVE STUDY; INTERMITTENT CLAUDICATION; MIDDLE AGED; MULTICENTER STUDY; PERIPHERAL ARTERIAL DISEASE; POSTOPERATIVE COMPLICATIONS;

AGED; AGED, 80 AND OVER; AXILLOFEMORAL BYPASS GRAFTING; ENDOVASCULAR PROCEDURES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 84893023134     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-1147     Document Type: Article

References (26)

1. Burns P, Gough S, Bradbury AW. Management of peripheral arterial disease in primary care. BMJ 2003; 326: 584-588.
2. Kasapis C, Gurm HS. Current approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic review. Curr Cardiol Rev 2009; 5: 296-311.
3. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004; 110: 738-743.
4. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): Multicentre, randomised controlled trial. Lancet 2005; 366: 1925-1934.
5. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45 (Suppl S): S5-S67.
6. Simons JP, Schanzer A, Nolan BW, Stone DH, Kalish JA, Cronenwett JL, et al. Outcomes and practice patterns in patients undergoing lower extremity bypass. J Vasc Surg 2012; 55: 1629-1636.
7. Eugster T, Marti R, Gurke L, Stierli P. Ten years after arterial bypass surgery for claudication: Venous bypass is the primary procedure for TASC C and D lesions. World J Surg 2011; 35: 2328-2331.
8. Soga Y, Yokoi H, Urakawa T, Tosaka A, Iwabuchi M, Nobuyoshi M. Long-term clinical outcome after endovascular treatment in patients with intermittent claudication due to iliofemoral artery disease. Circ J 2010; 74: 1689-1695.
9. Rogers JH, Laird JR. Overview of new technologies for lower extremity revascularization. Circulation 2007; 116: 2072-2085.
10. Scali ST, Rzucidlo EM, Bjerke AA, Stone DH, Walsh DB, Goodney PP, et al. Long-term results of open and endovascular revascularization of superficial femoral artery occlusive disease. J Vasc Surg 2011; 54: 714-721.
11. Soga Y, Mii S, Aihara H, Okazaki J, Kuma S, Yamaoka T, et al. Comparison of clinical outcome after bypass surgery vs. endovascular therapy for infrainguinal artery disease in patients with critical limb ischemia. Circ J 2013; 77: 2102-2109.
12. Wilson SE, Wolf GL, Cross AP. Percutaneous transluminal angioplasty versus operation for peripheral arteriosclerosis. Report of a prospective randomized trial in a selected group of patients. J Vasc Surg 1989; 9: 1-9.
13. Holm J, Arfvidsson B, Jivegard L, Lundgren F, Lundholm K, Schersten T, et al. Chronic lower limb ischaemia. A prospective randomised controlled study comparing the 1-year results of vascular surgery and percutaneous transluminal angioplasty (PTA). Eur J Vasc Surg 1991; 5: 517-522.
14. Siracuse JJ, Giles KA, Pomposelli FB, Hamdan AD, Wyers MC, Chaikof EL, et al. Results for primary bypass versus primary angioplasty/ stent for intermittent claudication due to superficial femoral artery occlusive disease. J Vasc Surg 2012; 55: 1001-1007.
15. Twine CP, McLain AD. Graft type for femoro-popliteal bypass surgery. Cochrane Database Syst Rev 2010; 5: CD001487.
16. van der Zaag ES, Legemate DA, Prins MH, Reekers JA, Jacobs MJ. Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial. Eur J Vasc Endovasc Surg 2004; 28: 132-137.
17. McQuade K, Gable D, Hohman S, Pearl G, Theune B. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg 2009; 49: 109-115, 116e1-116e9, discussion 116.
18. McQuade K, Gable D, Pearl G, Theune B, Black S. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol selfexpanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg 2010; 52: 584-590, discussion 590-591, 591e1-591e7.
19. Virkkunen J, Venermo M, Saarinen J, Keski-Nisula L, Apuli P, Kankainen AL, et al. Impact of endovascular treatment on clinical status and health-related quality of life. Scand J Surg 2008; 97: 50-55.
20. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: Twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010; 3: 267-276.
21. Rabellino M, Zander T, Baldi S, Garcia Nielsen L, Aragon-Sanchez FJ, Zerolo I, et al. Clinical follow-up in endovascular treatment for TASC C-D lesions in femoro-popliteal segment. Catheter Cardiovasc Interv 2009; 73: 701-705.
22. Connors G, Todoran TM, Engelson BA, Sobieszczyk PS, Eisenhauer AC, Kinlay S. Percutaneous revascularization of long femoral artery lesions for claudication: Patency over 2.5 years and impact of systematic surveillance. Catheter Cardiovasc Interv 2011; 77: 1055-1062.
23. Markose G, Miller FN, Bolia A. Subintimal angioplasty for femoropopliteal occlusive disease. J Vasc Surg 2010; 52: 1410-1416.
24. Dosluoglu HH, Cherr GS, Lall P, Harris LM, Dryjski ML. Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease. J Vasc Surg 2008; 48: 1166-1174.
25. Antoniou GA, Chalmers N, Georgiadis GS, Lazarides MK, Antoniou SA, Serracino-Inglott F, et al. A meta-analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease. J Vasc Surg 2013; 57: 242-253.
26. Miura T, Soga Y, Doijiri T, Aihara H, Yokoi H, Iwabuchi M, et al. Prevalence and clinical outcome of polyvascular atherosclerotic disease in patients undergoing coronary intervention. Circ J 2013; 77: 89-95.